BRVE
Braveheart Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$20.49
−4.20%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
—
Return on equity
—
Return on assets
—
Return on invested capital
—
Asset turnover
—
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period